HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$8.10
Year range
$1.25 - $10.53
Market cap
5.60B USD
Avg Volume
10.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 40.00K | -88.89% |
Operating expense | 95.24M | -14.92% |
Net income | -134.11M | -15.27% |
Net profit margin | -335.27K | -937.43% |
Earnings per share | — | — |
EBITDA | -90.64M | 15.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 170.50M | 86.81% |
Total assets | 400.68M | 16.68% |
Total liabilities | 1.09B | 24.74% |
Total equity | -690.98M | — |
Shares outstanding | 691.57M | — |
Price to book | -7.94 | — |
Return on assets | -52.59% | — |
Return on capital | -94.78% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -134.11M | -15.27% |
Cash from operations | -106.98M | -26.89% |
Cash from investing | -35.62M | -319.87% |
Cash from financing | 10.22M | -86.70% |
Net change in cash | -132.42M | -719.42% |
Free cash flow | -67.88M | -104.72% |
About
CEO
Founded
2014
Website
Employees
628